Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:OBIO NASDAQ:PDEX NASDAQ:RCEL NASDAQ:STRR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOBIOOrchestra BioMed$2.58-1.7%$2.83$2.37▼$6.50$99.88M0.61292,939 shs74,740 shsPDEXPro-Dex$33.17-5.8%$45.44$23.68▼$70.26$108.12M-0.0445,911 shs33,301 shsRCELAvita Medical$4.56+4.0%$5.12$3.60▼$14.16$120.19M1.58276,395 shs193,808 shsSTRRHudson Global$9.34+9.4%$2.91$8.26▼$16.79$25.41M0.3711,236 shs18,323 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOBIOOrchestra BioMed+0.38%-4.38%-3.68%-15.21%-53.95%PDEXPro-Dex-1.43%-23.07%-10.73%-11.05%+36.87%RCELAvita Medical+5.04%+2.10%-20.65%-20.94%-54.23%STRRHudson Global-13.65%+214.43%+324.88%+320.69%+104.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOBIOOrchestra BioMed$2.58-1.7%$2.83$2.37▼$6.50$99.88M0.61292,939 shs74,740 shsPDEXPro-Dex$33.17-5.8%$45.44$23.68▼$70.26$108.12M-0.0445,911 shs33,301 shsRCELAvita Medical$4.56+4.0%$5.12$3.60▼$14.16$120.19M1.58276,395 shs193,808 shsSTRRHudson Global$9.34+9.4%$2.91$8.26▼$16.79$25.41M0.3711,236 shs18,323 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOBIOOrchestra BioMed+0.38%-4.38%-3.68%-15.21%-53.95%PDEXPro-Dex-1.43%-23.07%-10.73%-11.05%+36.87%RCELAvita Medical+5.04%+2.10%-20.65%-20.94%-54.23%STRRHudson Global-13.65%+214.43%+324.88%+320.69%+104.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOBIOOrchestra BioMed 3.00Buy$13.50424.27% UpsidePDEXPro-Dex 3.00Buy$56.0068.85% UpsideRCELAvita Medical 2.40Hold$11.60154.67% UpsideSTRRHudson Global 2.00Hold$5.00-46.48% DownsideCurrent Analyst Ratings BreakdownLatest STRR, PDEX, RCEL, and OBIO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/5/2025RCELAvita MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$18.00 ➝ $14.009/4/2025OBIOOrchestra BioMedHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $10.008/20/2025OBIOOrchestra BioMedBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy ➝ Neutral8/14/2025STRRHudson GlobalMaxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold8/13/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$20.008/11/2025RCELAvita MedicalLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$14.00 ➝ $8.008/8/2025RCELAvita MedicalD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$19.00 ➝ $18.008/8/2025RCELAvita MedicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral ➝ Sell$3.008/7/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$20.00(Data available from 9/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOBIOOrchestra BioMed$2.64M37.69N/AN/A$0.87 per share2.96PDEXPro-Dex$66.59M1.62$2.91 per share11.39$11.23 per share2.95RCELAvita Medical$64.25M1.89N/AN/A$0.17 per share26.79STRRHudson Global$140.06M0.18N/AN/A$14.80 per share0.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOBIOOrchestra BioMed-$61.02M-$1.83N/AN/AN/A-2,367.49%-289.42%-110.04%11/11/2025 (Estimated)PDEXPro-Dex$8.98M$2.7012.2816.10N/A13.48%26.67%14.95%10/30/2025 (Estimated)RCELAvita Medical-$61.85M-$1.97N/AN/AN/A-68.87%-632.62%-71.52%11/6/2025 (Estimated)STRRHudson Global-$4.77M-$1.30N/AN/AN/A-2.81%-3.81%-2.84%11/18/2025 (Estimated)Latest STRR, PDEX, RCEL, and OBIO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/4/2025Q4 2025PDEXPro-Dex$0.47$0.36-$0.11$0.36$17.90 million$17.49 million8/13/2025Q2 2025STRRHudson Global-$0.26$1.86+$2.12$1.07$16.75 million$23.71 million8/12/2025Q2 2025OBIOOrchestra BioMed-$0.51-$0.50+$0.01-$0.50$0.78 million$0.84 million8/7/2025Q2 2025RCELAvita Medical-$0.26-$0.38-$0.12-$0.38$34.27 million$18.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthOBIOOrchestra BioMedN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ARCELAvita MedicalN/AN/AN/AN/AN/ASTRRHudson GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioOBIOOrchestra BioMed48.762.102.09PDEXPro-Dex0.253.231.71RCELAvita Medical9.390.580.46STRRHudson GlobalN/A3.043.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOBIOOrchestra BioMed53.20%PDEXPro-Dex15.28%RCELAvita Medical27.66%STRRHudson Global3.84%Insider OwnershipCompanyInsider OwnershipOBIOOrchestra BioMed8.10%PDEXPro-Dex47.50%RCELAvita Medical2.80%STRRHudson Global33.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOBIOOrchestra BioMed438.64 million35.51 millionNot OptionablePDEXPro-Dex1403.26 million1.71 millionNot OptionableRCELAvita Medical13026.62 million25.87 millionOptionableSTRRHudson Global1,3002.76 million1.83 millionNot OptionableSTRR, PDEX, RCEL, and OBIO HeadlinesRecent News About These CompaniesStar Equity Holdings, Inc. to Present at the Sidoti Small Cap Virtual Conference on September 17September 11 at 8:30 AM | globenewswire.comStar Equity completes $5M share repurchase authorizationSeptember 10 at 4:52 PM | msn.comStar Equity Holdings, Inc. Completes $5 Million Share Repurchase AuthorizationSeptember 10 at 8:30 AM | globenewswire.comStar Equity Holdings, Inc. RPO Subsidiary Rebrands to Hudson Talent SolutionsSeptember 8, 2025 | globenewswire.comHudson Global, Star Equity announce closing of mergerAugust 22, 2025 | msn.comStar Equity Holdings Approves Merger with Hudson SubsidiaryAugust 22, 2025 | msn.comHudson Global and Star Equity Holdings Announce Closing of MergerAugust 22, 2025 | globenewswire.comMaxim Group Downgrades Star Equity Holdings (STRR)August 15, 2025 | msn.comStar Equity downgraded to Hold from Buy at MaximAugust 14, 2025 | msn.comStar Equity Holdings Reports Strong Q2 2025 ResultsAugust 14, 2025 | msn.comStar Equity Holdings, Inc. (NASDAQ:STRR) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | insidermonkey.comStar Equity reports Q2 EPS $1.86 vs (29c) last yearAugust 13, 2025 | msn.comStar Equity Holdings, Inc. (STRR) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comStar Equity (STRR) Tops Q2 Earnings and Revenue EstimatesAugust 13, 2025 | zacks.comStar Equity Holdings, Inc. Announces 2025 Second Quarter Financial ResultsAugust 13, 2025 | globenewswire.comEarnings Outlook For Star Equity HldgsAugust 12, 2025 | benzinga.comStar Equity Holdings Inc (STRR) Q2 2025 Earnings Report Preview: What To ExpectAugust 12, 2025 | finance.yahoo.comStar Equity Holdings, Inc. Declares a Partial Cash Dividend of $0.225 Per Share of 10% Series A Cumulative Perpetual Preferred StockAugust 8, 2025 | globenewswire.comSTAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity Holdings, Inc. - STRRAugust 5, 2025 | businesswire.comStar Equity Holdings to Release Second Quarter 2025 Financial Results on August 13August 4, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSTRR, PDEX, RCEL, and OBIO Company DescriptionsOrchestra BioMed NASDAQ:OBIO$2.57 -0.05 (-1.91%) As of 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.Pro-Dex NASDAQ:PDEX$33.16 -2.03 (-5.75%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Avita Medical NASDAQ:RCEL$4.57 +0.19 (+4.22%) As of 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Hudson Global NASDAQ:STRR$9.24 +0.70 (+8.16%) As of 03:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Star Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Intel's Silent Comeback: 3 Pillars the Market Is Overlooking Palantir’s Defense Partnerships Fuel Its Growth Story It May Be Time to Buy the Dip in Texas Instruments Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
